1067092

Bayer Healthcare Pharmaceuticals Inc. — FEI 2243252

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 9, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Whippany, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)